Medical News

RSS

Revolutionary way for consumers to create their own customized workout

Because no two people are exactly alike, shouldn’t each person’s fitness routine be just as unique? With the Oct. 4 launch of Wii Fit Plus™, Nintendo introduces a revolutionary way for consumers to create their own customized workout, delivering new levels of personalization, convenience and enjoyment to at-home fitness.

5 Oct 2009

BJC HealthCare facility to implement OptiFlex supply management solution for hospital operating rooms

Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that Barnes-Jewish Hospital, named as one of "America's Best Hospitals" in the U.S. News & World Report Honor Roll 2009-10, will be the first BJC HealthCare facility to implement the OptiFlex point-of-use supply systems for their hospital operating rooms.

5 Oct 2009

VIVUS to present data on Qnexa at The Obesity Society meeting

VIVUS, Inc. today announced that data on Qnexa(TM), an investigational new drug, will be presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley Day, PhD, vice president of clinical development at VIVUS, will present data from the company's two year long phase 3 obesity trials, and Dr. Timothy Garvey, MD, professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham, will present data from the year long phase 2 study in type 2 diabetics.

5 Oct 2009

ACS to establish EHR and HIE interoperability for Wyoming Department of Health

Affiliated Computer Services, Inc. (NYSE: ACS), today announced a $4 million, three-year contract to provide the State of Wyoming with powerful tools to improve care for Medicaid clients and reduce program costs.

5 Oct 2009

Phase 3 clinical study results of Ketotransdel topical cream to be presented

Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.

5 Oct 2009

Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

Baxter International Inc. today announced the commercial launch of HYLENEX recombinant (hyaluronidase human injection) for use in pediatric rehydration at the 2009 American College of Emergency Physicians (ACEP) scientific assembly (Boston). HYLENEX, an enzyme, allows fluids to be administered under the skin (subcutaneously) rather than through a vein.

From Baxter International Inc. 5 Oct 2009

Innovative health care information technology solutions to improve quality of patient care

Methodist Hospital of Arcadia, California, has launched an integrated deployment of innovative health care information technology (HIT) solutions designed to help improve the quality of patient care and deliver operational efficiencies. MedPlus®, the health care information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), provided the integrated solution to help Methodist reduce the length of stay associated with patients and help realize gains in efficiency and revenue.

5 Oct 2009

PrimeraDx receives its fourth patent

PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has received its fourth patent. The patent, entitled “Methods and systems for dynamic gene expression profiling”, with inventor Vladimir Slepnev, Ph.D., describes a novel method of quantitative analysis of gene expression allowing simultaneous interrogation of multiple genes in a single tube reaction.

5 Oct 2009

Majority of Americans believe they are well-protected from H1N1

A new Harris poll, commissioned by SCA Tissue North America’s Tork® brand, reveals that 74 percent of U.S. adults say it is unlikely they will contract H1N1 this year.

5 Oct 2009

Preclinical study results of AVL-181 protease inhibitor presented

Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.

5 Oct 2009

FDA grants Impax tentative approval of ANDA for FLOMAX generic version

Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company’s Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.

5 Oct 2009

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

Peregrine Pharmaceuticals, Inc. today reported additional positive results in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC). Data previously reported from the initial cohort of 21 patients in the study had indicated that 11 of 17 evaluable patients with locally advanced or metastatic NSCLC achieved an objective tumor response according to RECIST criteria.

5 Oct 2009

ABC of fitness etiquette

Whether you are a gym expert or a fitness center novice, you've probably seen your share of interesting and sometimes amusing etiquette faux pas: the grunter, the space invader, the cell phone talker and the, ehem, "fragrant neighbor."

5 Oct 2009

New consumer At-Home Skin Typing and Analysis Kit unveiled

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.

5 Oct 2009

Novo Nordisk initiates its share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

From Novo Nordisk 5 Oct 2009

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.

5 Oct 2009

Discus Dental to host 2010 Las Vegas Extravaganza

Discus Dental®, LLC, innovators in dental and oral-hygiene products and the worldwide leader in professional teeth whitening products, today announced the company will be hosting its 2010 Las Vegas Extravaganza, featuring keynote speaker, former NBC news anchor Tom Brokaw.

5 Oct 2009

avVaa World Health Care Products launches Neuroskin Psoriasis Relief DRTV media test campaign

avVaa World Health Care Products Inc. a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the launch of its two week Neuroskin(R) Psoriasis Relief DRTV media test campaign.

5 Oct 2009

BronxRHIO to deploy Axolotl's health information exchange solutions

The Bronx Regional Health Information Organization today announced that it has signed an agreement with Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services. The BronxRHIO, a not-for-profit organization established by the borough’s leading healthcare organizations, will deploy Axolotl’s Elysium® Exchange suite of solutions to enable healthcare providers to securely access and share clinical information, with a goal of reducing healthcare costs and improving the quality of patient care.

5 Oct 2009

Millennium Administrators named to the Philadelphia 100 for helping employers to control healthcare costs

Millennium Administrators, a healthcare consulting firm specializing in administering employee healthcare benefits, has been recognized as one of the fastest growing companies the Greater Philadelphia Region. Millennium was named to the Philadelphia 100 for the second time in the past three years.

5 Oct 2009